TrialTechnology in cancer research & treatment

A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer.

Can Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.